In order to study whether FAM168A participates in the development of CML, we first examined the expression of FAM168A in CML cells and found that FAM168A mRNA and protein expressions increased in PBMCs of CML patients. The gene discussed is FAM168A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.